Thursday, Nov 20 — Sai Life Sciences Ltd has informed the exchanges that it has received an order from the Joint Commissioner of Commercial Taxes (Appeals), Kalaburagi, raising a GST demand related to intermediary services received from its US subsidiary. The order, dated November 19, 2025, was issued under Section 107(11) of the Karnataka Goods and Services Tax Act, 2017 and the Central Goods and Services Tax Act, 2017.

According to the company’s disclosure, the total demand includes IGST of Rs 20,84,77,738, interest of Rs 13,75,10,920, and penalty of Rs 2,08,47,774. The dispute pertains to taxability under the reverse charge mechanism for the period between July 2017 and March 2022.

Sai Life Sciences stated that it has assessed the matter and will be filing an appeal against the order. The company said it remains “hopeful of a favourable outcome at the Tribunal level” and does not expect any material financial impact arising from the order at this stage.

The communication was received by the company at 4:10 PM on November 19 and disclosed to both NSE and BSE under Regulation 30 of the SEBI LODR Rules.